Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Study was terminated prematurely on October 16, 2015 following FDA decision to release Sponsor from post-marketing commitment. No safety and/or efficacy concerns identified.
Age
12–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patient, aged 12 to 17 years.
Requires outpatient treatment for acute pharyngitis/tonsillitis infection.
Appropriate to treat with oral azithromycin as an alternative to intramuscular penicillin, in the opinion of the investigator.
Positive rapid antigen detection test.
You may not be if
History of clinically significant eye disorder that would interfere with protocol test procedures.
Hypersensitivity to azithromycin, erythromycin, any macrolide, or ketolide antibiotic.
